- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04584138
Autobiographical Memory (EMAM)
March 22, 2023 updated by: Nantes University Hospital
Eye Movement During Autobiographical Memory in Alzheimer's Disease
This study aims at the assessment of eye movement during autobiographical retrieval (i.e., retrieval of personal memories) in patients with Alzheimer's Disease.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
There is an increased interest in the study of eye movements during the retrieval of autobiographical memories and recent research has demonstrated how retrieval of autobiographical memory can activate eye movement.
This research has been however mainly concerned with young adults and, until now, little is known about the relationship between eye movement and autobiographical memory in patients with Alzheimer's Disease.
The aim of the current study is therefore to evaluate eye movements during the retrieval of autobiographical memories in patients with Alzheimer's Disease.
Study Type
Observational
Enrollment (Actual)
54
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Claire BRETONNIERE, MD
- Phone Number: 33240083333
- Email: claire.boutoleaubretonniere@chu-nantes.fr
Study Locations
-
-
-
Nantes, France, 44000
- CHU de Nantes
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 100 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients diagnosed with Alzheimer's disease in the mild stage
Description
Inclusion Criteria :
- Diagnosis of Alzheimer's Disease at the mild stage
Exclusion Criteria :
- Neurological/psychiatric disorders (other than Alzheimer's Disease)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of fixations and saccades
Time Frame: Four weeks (from assessment till analysis)
|
Number
|
Four weeks (from assessment till analysis)
|
Duration of fixations and saccades
Time Frame: Four weeks (from assessment till analysis)
|
Duration in milliseconds
|
Four weeks (from assessment till analysis)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pupil size
Time Frame: Four weeks (from assessment till analysis)
|
In millimeter
|
Four weeks (from assessment till analysis)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 15, 2021
Primary Completion (Actual)
November 25, 2022
Study Completion (Actual)
November 25, 2022
Study Registration Dates
First Submitted
September 23, 2020
First Submitted That Met QC Criteria
October 9, 2020
First Posted (Actual)
October 12, 2020
Study Record Updates
Last Update Posted (Actual)
March 23, 2023
Last Update Submitted That Met QC Criteria
March 22, 2023
Last Verified
March 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RC20_0322
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alzheimer's Disease
-
University of Southern CaliforniaAlzheimer's Therapeutic Research Institute; American Heart Association; Schaeffer...RecruitingDementia | Alzheimer Disease | Prodromal Alzheimer's Disease | Preclinical Alzheimer's DiseaseUnited States
-
University of Southern CaliforniaNational Institute on Aging (NIA); Alzheimer's Therapeutic Research Institute; Brigham and Women's Hospital and other collaboratorsActive, not recruitingDementia | Alzheimer Disease | Prodromal Alzheimer's Disease | Preclinical Alzheimer's DiseaseUnited States
-
Novoic LimitedRecruitingAlzheimer Disease | Mild Cognitive Impairment | Prodromal Alzheimer's Disease | Alzheimer's Disease (Incl Subtypes) | Preclinical Alzheimer's DiseaseUnited States
-
Novoic LimitedRecruitingAlzheimer Disease | Mild Cognitive Impairment | Prodromal Alzheimer's Disease | Alzheimer's Disease (Incl Subtypes) | Preclinical Alzheimer's DiseaseUnited Kingdom
-
Novoic LimitedCompletedAlzheimer Disease | Mild Cognitive Impairment | Prodromal Alzheimer's Disease | Alzheimer's Disease (Incl Subtypes) | Preclinical Alzheimer's DiseaseUnited States
-
Novoic LimitedCompletedAlzheimer Disease | Mild Cognitive Impairment | Prodromal Alzheimer's Disease | Alzheimer's Disease (Incl Subtypes) | Preclinical Alzheimer's DiseaseUnited Kingdom
-
Novoic LimitedRecruitingAlzheimer Disease | Mild Cognitive Impairment | Prodromal Alzheimer's Disease | Alzheimer's Disease (Incl Subtypes) | Preclinical Alzheimer's DiseaseUnited Kingdom
-
Novoic LimitedRecruitingAlzheimer Disease | Mild Cognitive Impairment | Prodromal Alzheimer's Disease | Alzheimer's Disease (Incl Subtypes) | Preclinical Alzheimer's Disease | Normal CognitionUnited States
-
University Hospital, BordeauxMinistry for Health and Solidarity, FranceCompletedAlzheimer's Disease (AD) | Alzheimer's Disease (AD) Related DisordersFrance
-
University of Colorado, DenverNational Institute on Aging (NIA)Active, not recruitingSuspected Typical Alzheimer's Disease (AD) | Suspected Atypical Alzheimer's Disease (AD)United States
Clinical Trials on Study of eye movements
-
University of ZurichHarvard Medical School (HMS and HSDM); Massachusetts General HospitalCompleted
-
University Hospital, CaenCompleted
-
Nantes University HospitalTerminatedCentral or Peripheral Visual ImpairmentFrance
-
University Hospital, CaenUnknown
-
Qilu Hospital of Shandong UniversityShandong UniversityRecruitingNervous System Diseases | Parkinson Disease | Alzheimer Disease | Geriatric DiseasesChina
-
Ege UniversityEnrolling by invitationAlcohol Use Disorder | Alcohol CravingTurkey
-
US Department of Veterans AffairsCompletedRetinal Degeneration | Age Related MaculopathyUnited States
-
West Kazakhstan Medical UniversityRecruitingCerebral Palsy | Neurologic Disorder | Pediatric Disorder | Child Behavior DisordersKazakhstan
-
Centre Hospitalier Universitaire de BesanconCentre Hospitalier Universitaire Dijon; Laboratoire de psychologie EA 3188; Centre...UnknownDepression | Alzheimer DiseaseFrance
-
University of SalernoAzienda Ospedaliero, Universitaria Pisana; Azienda Ospedaliera di PadovaRecruiting